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The improper use of medicines is a major cause of poor therapeutic effect as well as 
adverse drug reactions, and has considerable financial consequences (1-4). In the 
present era of global economic recession, there is a need for a judicious use of 
resources to cater for all citizens in developing countries. Therefore, the promotion of 
the Rational Use of Medicines (RUM) should be a healthcare priority in African 
countries. Still there is limited information on how appropriate medicines are prescribed 
and used in Africa (5).   
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In order to progress research on RUM, a planning meeting to establish collaboration 
across countries in Africa met in Port-Elizabeth in South Africa in January 2015. 
Professor Ilse Truter at The Nelson Mandela University was the host of the meeting that 
was initiated together with representatives from the IUPHAR Subcommittee. The 
meeting drew participants from South Africa, Botswana, Kenya, Namibia, Nigeria, 
Swaziland, Sweden and the United Kingdom. African delegates discussed their current 
research on drug utilization while the European participants (Jaran Eriksen and Brian 
Godman) reviewed ongoing cross-country projects in African countries (5). The 
discussion in Port-Elizabeth centered on the needs for an interdisciplinary and 
multinational group of healthcare professionals to foster drug utilization research in 
Africa. Subsequently the Medicines Utilization Research in Africa (MURIA) group was 
formed. The promotion of RUM in Africa is to be achieved through training, 
collaboration, sharing of information and facilitation of access to data across Africa. This 
meeting started the planning of a 2.5 day training workshop and symposium targeting 
African scientists to be hosted by the University of Botswana in July, 2015 co-organized 
by MURIA, University of Botswana, Karolinska Institutet in Sweden and IUPHAR.  
 
This first MURIA workshop (1.5 days) and symposium (1 day) was made possible by 
funding from the Swedish Research Council, the University of Botswana, the Ministry of 
Health in Botswana and IUPHAR and its clinical division. The meeting took place at the 
University of Botswana from 27th to 29th July 2015. The meeting was opened by the 
Honourable Minister for Health Dorcas Makgato of the Republic of Botswana (Figure 1). 
She dwelt on the emerging problems of antimicrobial resistance and emphasized the 
need to promote RUM of especially antibiotics, anti-TB drugs and antiretrovirals (ARVs). 
She also addressed the issue of non-communicable diseases and the importance of 
generic medicines in the reduction of healthcare costs and improving access to 
medicines (6).The delegates included 103 physicians, pharmacists and other healthcare 
professionals from the academia, medical aid schemes and government agencies from 
8  African countries and from Australia, Saudi Arabia, Sweden and United Kingdom. 
Participants were researchers from universities, practicing physicians and pharmacists, 
representatives from ministries of health and national l agencies in the healthcare 
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sector. As many as 20 pharmacists from regional pharmacy service units across 
Botswana took part in the meeting.  
 
The workshop, which was interactive, provided choices for both introductory or 
advanced workshops on drug utilization methods and research. The introductory group 
dealt with topics such as sources of drug utilization data, drug classification systems 
such as the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) 
concepts, use of DDDs/1000 inhabitants/day (DIDs) to assess drug utilization across 
countries and standard drug use indicators.  The different approaches of influencing 
RUM (education, economics, engineering and enforcement) were also discussed. The 
main issue dealt with by the advanced group included antibiotic drug utilization 
research, assessment of antibiotic prescribing, use of qualitative methods in drug 
utilization research, challenges for comparative cross-national and pharmacoeconomics 
studies in Africa. The use of questionnaires and household surveys for drug utilization 
research was highlighted during the second day of the workshop. Other topics 
discussed were the importance of ethics and practical challenges in drug utilization 
research, use of databases in the exploration of drug safety, importance of 
communications in drug utilization research as exemplified by high level of adherence to 
WKH³:LVH/LVW´E\SK\VLFians in Sweden (7).  
 
The workshop was followed by a symposium during one day with 18 oral and 18 poster 
presentations. The theme of most oral and poster presentations centered around the 
utilization of antibiotics, the adverse effect profile of ARVs, antihypertensives, 
anticonvulsants, medication adherence and generic medicines (6). Based on these 
presentations, the participants agreed to focus on collaborative drug utilization research 
in the following disease conditions: HIV/TB, malaria, central nervous system and non-
communicable diseases (diabetes mellitus, hypertension, cancer). Research 
collaboration in the area of generic medicines, drug utilization using databases and 
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economic aspects of drug use was also discussed. Interested participants were tasked 
to drive the various topics identified. The African e-Infrastructures discussion and 
collaboration forum of the African Pharmacology Science Gateway (www.sci-gaia.eu/) 
will be used to facilitate access to resources and interactions which enhance research 
and capacity building across Africa (8). Membership of MURIA Group 
(www.muria.nmmu.ac.za/)  is open at no cost to professionals from the Academia, healthcare 
institutions and Regulatory Bodies. The next meeting is planned to July 2016. The 
Gaborone meeting has the potential to become the starting point for introduction of drug 
utilization methods and studies across African countries to improve RUM, which will 
necessarily broaden the impact of clinical pharmacologists in African countries. 
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Figure 1: Honourable minister of Health in Botswana Dorcas Makgato gave the 
inauguration speech for the MURIA Workshop and Symposium arranged in 
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collaboration with IUPHAR on July 27 to 29, 2015 at the University of Botswana in 
Gaborono. (Photo Lars L Gustafsson) 
 
Figure 2: Participants at the first MURIA Workshop and Symposium co-organized by 
IUPHAR Subcommittee for Clinical Pharmacology in Developing Countries in 
Gaborone, Botswana, July 27-29, 2015 (Photo Lars L Gustafsson) 
 
 
 
 
